To Örebro University

oru.seÖrebro University Publications
Planned maintenance
A system upgrade is planned for 10/12-2024, at 12:00-13:00. During this time DiVA will be unavailable.
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Serum thymidine kinase 1 and its kinetics in HER2-positive breast cancer: Results from the Swedish phase II PREDIX HER2 trial
Show others and affiliations
2022 (English)In: Journal of Clinical Oncology, ISSN 0732-183X, E-ISSN 1527-7755, Vol. 40, no 16, article id e12598Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
American Society of Clinical Oncology , 2022. Vol. 40, no 16, article id e12598
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:oru:diva-102115ISI: 000863680302501OAI: oai:DiVA.org:oru-102115DiVA, id: diva2:1709670
Available from: 2022-11-09 Created: 2022-11-09 Last updated: 2022-11-09Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records

Dreifaldt, Ann Charlotte

Search in DiVA

By author/editor
Dreifaldt, Ann Charlotte
By organisation
School of Medical Sciences
In the same journal
Journal of Clinical Oncology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 40 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf